Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.

Vicky MakkerMatthew H TaylorCarol AghajanianAllen L CohnMarcia S BroseChristopher Di SimoneZhu Alexander CaoLeah SuttnerAndrey LobodaRazvan CristescuPetar JelinicRobert OrlowskiLea DuttaJunji MatsuiCorina E DutcusYukinori MinoshimaMark J Messing

Published in: Journal for immunotherapy of cancer (2024)

NCT02501096.

Keyphrases

endometrial cancer
randomized controlled trial
clinical trial
phase ii
tyrosine kinase
double blind